Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Shaw

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2013
Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantationRadojka M Savic, Morton J Cowan, Christopher C Dvorak, et al.
Journal of Paediatrics and Child Health|October 25, 2020
Diagnosis and management of severe combined immunodeficiency in Australia and New ZealandStephanie Richards, Andrew R Gennery, E Graham Davies, et al.
Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.
Haematologica|March 4, 2017
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeZhanna Shekhovtsova, Carmem Bonfim, Annalisa Ruggeri, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.
Blood|March 24, 2017
Monitoring of childhood ALL using <i>BCR-ABL1</i> genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2013
Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantationRadojka M Savic, Morton J Cowan, Christopher C Dvorak, et al.
Journal of Paediatrics and Child Health|October 25, 2020
Diagnosis and management of severe combined immunodeficiency in Australia and New ZealandStephanie Richards, Andrew R Gennery, E Graham Davies, et al.
Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.
Haematologica|March 4, 2017
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeZhanna Shekhovtsova, Carmem Bonfim, Annalisa Ruggeri, et al.
Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
Pageof 14